statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...

Why Lantheus Holdings Stock Is Skyrocketing Today

Why Lantheus Holdings Stock Is Skyrocketing Today...

Evaluating Lantheus Holdings: Insights From 5 Financial Analysts

Latest Ratings for LNTH
 DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Jul 2021SVB LeerinkMaintainsOutperform May 2021Credit SuisseMaintainsNeutral
 View More Analyst Ratings for...

Lantheus Holdings (LNTH, $60.11) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

This is a Bullish indicator signaling LNTH's price could rise from here. Traders may explore going long the stock or buying call options...

Interesting LNTH Put And Call Options For May 17th

Investors in Lantheus Holdings Inc (LNTH) saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LNTH...

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers...

Lantheus Holdings (LNTH, $60.46) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

This indicator may be signaling LNTH's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Acadia (ACHC) Starts Construction of Malden's JV Facility

Acadia Healthcare Company, Inc. ACHC recently commenced the construction of a behavioral health hospital in Malden, MA. The facility, equipped with 144 beds, will be built as a result of the joint...

Here's Why You Should Add Lantheus (LNTH) to Your Portfolio

Lantheus Holdings, Inc. LNTH has been gaining from its focus on pipeline development. The optimism led by a solid fourth-quarter 2023 performance and strength in radiopharmaceuticals is expected to...

Lantheus Holdings (LNTH, $58.44) price moved above its 50-day Moving Average on March 19, 2024

This price move could indicate a change in the trend, and may be a buy signal for investors...

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Volume	688,820.00
52-Wk High	$126.89
52-Wk Low	$50.20

LNTH Lantheus Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals